abrdn plc Has $3.97 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

abrdn plc grew its position in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 40.0% during the 4th quarter, Holdings Channel reports. The firm owned 111,494 shares of the medical instruments supplier’s stock after purchasing an additional 31,852 shares during the quarter. abrdn plc’s holdings in DENTSPLY SIRONA were worth $3,968,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Beach Investment Counsel Inc. PA grew its position in DENTSPLY SIRONA by 1.4% during the 4th quarter. Beach Investment Counsel Inc. PA now owns 22,125 shares of the medical instruments supplier’s stock worth $787,000 after acquiring an additional 306 shares during the last quarter. Tokio Marine Asset Management Co. Ltd. grew its holdings in shares of DENTSPLY SIRONA by 5.4% during the third quarter. Tokio Marine Asset Management Co. Ltd. now owns 6,950 shares of the medical instruments supplier’s stock worth $237,000 after purchasing an additional 359 shares during the last quarter. VisionPoint Advisory Group LLC increased its stake in shares of DENTSPLY SIRONA by 104.2% in the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock valued at $26,000 after buying an additional 395 shares in the last quarter. Teacher Retirement System of Texas raised its holdings in shares of DENTSPLY SIRONA by 2.5% in the third quarter. Teacher Retirement System of Texas now owns 16,471 shares of the medical instruments supplier’s stock valued at $563,000 after buying an additional 397 shares during the last quarter. Finally, Exchange Traded Concepts LLC lifted its position in DENTSPLY SIRONA by 41.2% during the 3rd quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier’s stock worth $51,000 after buying an additional 439 shares in the last quarter. Institutional investors own 95.70% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have weighed in on the stock. Needham & Company LLC restated a “buy” rating and issued a $42.00 price objective on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. Piper Sandler boosted their price objective on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a “neutral” rating in a research report on Friday, January 12th. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Friday, January 19th. Leerink Partnrs reissued an “outperform” rating on shares of DENTSPLY SIRONA in a research note on Monday, February 26th. Finally, SVB Leerink initiated coverage on DENTSPLY SIRONA in a research report on Monday, February 26th. They set an “outperform” rating and a $42.00 target price for the company. Three investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat, DENTSPLY SIRONA has a consensus rating of “Moderate Buy” and an average price target of $39.50.

Read Our Latest Report on XRAY

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $30.57 on Monday. The firm has a fifty day moving average of $32.53 and a two-hundred day moving average of $32.78. The company has a current ratio of 1.38, a quick ratio of 0.95 and a debt-to-equity ratio of 0.55. DENTSPLY SIRONA Inc. has a 52 week low of $26.27 and a 52 week high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its quarterly earnings data on Thursday, February 29th. The medical instruments supplier reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.43 by $0.01. DENTSPLY SIRONA had a positive return on equity of 11.14% and a negative net margin of 3.33%. The business had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $972.61 million. During the same quarter in the prior year, the company posted $0.46 earnings per share. The firm’s revenue was up 3.0% on a year-over-year basis. As a group, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current year.

DENTSPLY SIRONA Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.09%. This is an increase from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date of this dividend was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -103.22%.

About DENTSPLY SIRONA

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.